Dermatitis clinical trials

The registry lists 1,435 studies for Dermatitis across more than 10 countries. 131 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,435 — search for more.

• Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 21 country
• Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).Not yet recruitingNCT078126751 country
• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaRecruitingNCT06807268Phase 38 countries
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruitingNCT07765888Phase 31 country
• Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis PatientsNot yet recruitingNCT07620561Phase 21 country
• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruitingNCT07599813Phase 28 countries
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaNot yet recruitingNCT07783425Phase 31 country
• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT06947993Phase 217 countries
• Multi-Omic SignAtures of Inflammatory Cutaneous DiseasesNot yet recruitingNCT07771673
• A Study of Lebrikizumab in Adults With Nummular EczemaRecruitingNCT07542483Phase 31 country
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruitingNCT07037901Phase 24 countries
• Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT07734415Phase 22 countries
• Mepitel Film BreastRecruitingNCT077294231 country
• Evolution of Chronic Inflammatory Skin DiseasesNot yet recruitingNCT077088961 country
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.RecruitingNCT056891511 country
• First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic DermatitisRecruitingNCT07527923Phase 11 country
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataEnrolling by invitationNCT039766221 country
• Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Skin MicrobiotaNot yet recruitingNCT07583121Not applicable1 country
• Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept TrialRecruitingNCT07341087Not applicable1 country
• Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksRecruitingNCT07014007Not applicable1 country
• A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 WeeksNot yet recruitingNCT07519174Not applicable1 country
• A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy SubjectsRecruitingNCT07414602Phase 11 country
• Prospective Longitudinal Observational Research in Atopic DermatitisRecruitingNCT042405221 country
• Reducing Skin Side Effects in Patients Receiving Radiation on TomotherapyNot yet recruitingNCT07357506Not applicable
• PMCF Investigation of Medical Device ChitoCare® MedicalRecruitingNCT068503891 country
• Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.RecruitingNCT06855745Phase 21 country
• Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical ParametersRecruitingNCT07056569Not applicable1 country
• A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic DermatitisRecruitingNCT07022288Not applicable1 country
• National Register of Moderate and Severe Adult Atopic DermatitisRecruitingNCT063133331 country
• Photobiomodulation in Radiodermatitis in People With Breast CancerNot yet recruitingNCT06990165Not applicable1 country
• Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic DermatitisRecruitingNCT06636240Not applicable1 country
• Multi-modal Quantitative Imaging of the SkinRecruitingNCT069892161 country
• Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone PositionRecruitingNCT06915857Phase 31 country
• Short and Ultra-short-pulse ND: YAG 1064nm Lasers (Omer Smart and Omer Premium) for Stasis DermatitisRecruitingNCT06980961Not applicable1 country
• Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT06956196Phase 31 country
• Characterisation of Skin Microstructure Under Normal and Atrophied StatesRecruitingNCT069542721 country
• Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerlandRecruitingNCT058194631 country
• Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis ChildrenEnrolling by invitationNCT06947252Not applicable1 country
• Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic DermatitisRecruitingNCT06930365Not applicable1 country
• BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic DermatitisRecruitingNCT035494161 country
• Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.RecruitingNCT05575882Not applicable3 countries
• A Phase Ⅲ Comparative Study of QL2108 to Dupixent®Not yet recruitingNCT06884891Phase 3
• A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic DermatitisEnrolling by invitationNCT06158490Phase 21 country
• Drug Survival of Target Therapies in Atopic DermatitisRecruitingNCT068821481 country
• Herbal Ointment in Treating Atopic Dermatitis TopicallyRecruitingNCT06850311Phase 2/31 country
• Microbiome in Atopic Dermatitis Under Systemic TherapyRecruitingNCT050993151 country
• A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants with Moderate-to-Severe Atopic DermatitisRecruitingNCT068153801 country
• Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECTRecruitingNCT059384781 country
• A Basket Trial of Vunakizumab in Inflammatory Skin DiseasesNot yet recruitingNCT06794671
• A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabRecruitingNCT06524635Phase 21 country